BRILINTA

BRILINTA

  • 8/25/2011
  • AstraZeneca Pharmaceuticals
  • Ticagrelor 90mg; tablets.
  • To reduce the rate of thrombotic cardiovascular (CV) events in patients with acute coronary syndrome (ACS) (unstable angina or non-ST-elevation myocardial infarction [MI] or ST-elevation MI).
XARELTO

XARELTO

  • 7/28/2011
  • Janssen Therapeutics
  • Rivaroxaban 10mg; tablets.
  • To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism in patients undergoing knee or hip replacement surgery.
PRADAXA

PRADAXA

  • 11/12/2010
  • Boehringer Ingelheim Pharmaceuticals
  • Dabigatran etexilate mesylate 75mg, 150mg; caps.
  • To reduce risk of stroke and systemic embolism in non-valvular atrial fibrillation.

Sign Up for Free e-newsletters